Am. J. Respir. Crit. Care Med., Volume 156, Number 5, November 1997, 1556-1561

Comparison of Train-of-Four and Best Clinical Assessment during Continuous Paralysis

CHARLIE STRANGE, LEIGH VAUGHAN, CHERYL FRANKLIN, and JIM JOHNSON

Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina

Train-of-four (TOF) monitoring is recommended in published guidelines during use of continuous- infusion neuromuscular blocking agents (NMB) in the intensive care unit (ICU). To test that recommendation, dual protocols were established in a medical ICU after intensive nursing education. Paralyzed patients received either TOF monitoring with a goal of three twitches or best clinical assessment while receiving atracurium by continuous infusion. Demographics and mean duration of paralysis of 20 patients in the TOF group were no different than that of the 16 patients in the best clinical assessment group. Although most patients demonstrated atracurium tolerance over time, there was no difference between groups in total mg (± SEM) infused (10,460 ± 2,409 versus 9,201 ± 3,237) or mean µg/kg/min (15.2 ± 1.5 versus 12.0 ± 1.1). The time to clinical recovery was no different between groups (50 ± 10 versus 45 ± 12 min). Two complications occurred in the TOF group, with pulmonary emboli despite prophylaxis and an unrecognized cerebrovascular accident in one patient each. We conclude that careful titration of NMB using clinical bedside markers should remain the standard of care with these drugs.

This article has been cited by other articles:

				L. Corso Train-of-Four Results and Observed Muscle Movement in Children During Continuous Neuromuscular Blockade Crit. Care Nurse, June 1, 2008; 28(3): 30 - 38. [Full Text] [PDF]

				A. Arroliga, F. Frutos-Vivar, J. Hall, A. Esteban, C. Apezteguia, L. Soto, A. Anzueto, and for the International Mechanical Ventilation Study Use of Sedatives and Neuromuscular Blockers in a Cohort of Patients Receiving Mechanical Ventilation Chest, August 1, 2005; 128(2): 496 - 506. [Abstract] [Full Text] [PDF]

				C. N. Sessler Train-of-Four To Monitor Neuromuscular Blockade? Chest, October 1, 2004; 126(4): 1018 - 1022. [Full Text] [PDF]

				M. H. Baumann, B. W. McAlpin, K. Brown, P. Patel, I. Ahmad, R. Stewart, and M. Petrini A Prospective Randomized Comparison of Train-of-Four Monitoring and Clinical Assessment During Continuous ICU Cisatracurium Paralysis Chest, October 1, 2004; 126(4): 1267 - 1273. [Abstract] [Full Text] [PDF]

				S. Deem, C. M. Lee, and J. R. Curtis Acquired Neuromuscular Disorders in the Intensive Care Unit Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 735 - 739. [Full Text] [PDF]

				G. Dhonneur, C. Cerf, F. Lagneau, J. Mantz, C. Gillotin, and P. Duvaldestin The Pharmacokinetics of Cisatracurium in Patients with Acute Respiratory Distress Syndrome Anesth. Analg., August 1, 2001; 93(2): 400 - 404. [Abstract] [Full Text] [PDF]

				D. Hackner, G. Tu, S. Weingarten, and Z. Mohsenifar Guidelines in Pulmonary Medicine: A 25-Year Profile Chest, October 1, 1999; 116(4): 1046 - 1062. [Abstract] [Full Text] [PDF]